Description: This research examines the intersection of US insurance ratemaking and analytics techniques in advanced modern rating systems and associated regulatory considerations in the US.

Description: Research report that explores key factors associated with an insurer’s reputational risk and conditions that would generate incentives for insurers to behave in a way that causes loss of their positive reputation.

Description: This report documents updates to the Canadian mortality data in both the Human Mortality Database and the Canadian Human Mortality Database, including new data for 2022–2023.

Description: Credibility is a mechanism for estimating a quantity of interest by combining subject experience and relevant experience to improve the estimate.

Description: This report outlines a methodology for estimating mortality improvement factors based on data from insured lives. The report details challenges, methodology, results, comparisons with population data, limitations, and potential improvements.

Description: An overview of the objectives of outbreak modeling, and an examination of the various types of models used both to forecast an uncontrolled outbreak, and to estimate the effects of interventions intended to alter the outbreak’s trajectory

Description: Cost Effectiveness of Tumor Genomic Analysis and Immunotherapy

Description: The SOA’s Artificial Intelligence Working Group explored the role of AI in actuarial practice, focusing on risk management, regulatory compliance, and ethical considerations. The discussion highlighted the importance of the NIST AI Risk Management Framework and Generative AI Profile in ensuring responsible AI development and deployment in insurance and healthcare.

Description: This Society of Actuaries, working with LIMRA, Oliver Wyman and the American Council of Life Insurers, is releasing a series of pulse surveys aimed at obtaining a quick read on how the COVID-19 pandemic is impacting insurance companies and reinsurers.

Description: In the past months, as COVID-19 has forced the reduced activity in the U.S. economy there has been some very substantial, but varied effects on the U.S. healthcare system. There is a lot of potential for confusion amongst providers and patients with regards to decisions related to which services ought to be rendered and which ought to be deferred. Two specific agencies – the Centers for Medicare and Medicaid Services (CMS), and the American College of Surgeons (ACS) have put together some guidance to add more clarity towards what types of services should be provided and what types ought to be deferred. In addition, this paper includes a discussion on what types of services are most likely to be deferred, and which ones will accrue pent-up demand to be released when many of the deferred services become available again.